Literature DB >> 7380831

Human adenosine deaminase and its binding protein in normal and adenosine deaminase-deficient fibroblast cell strains.

P E Daddona, M A Frohman, W N Kelley.   

Abstract

Reduced or absent adenosine deaminase activity occurs in all tissues of some patients with severe combined immunodeficiency disease. In this report we describe (a) a sensitive and specific radioimmunoassay for fibroblast adenosine deaminase and its binding protein, (b) the importance of various tissue culture media on the expression of fibroblast adenosine deaminase, and (c) the levels of immunoreactive adenosine deaminase compared to its binding protein in normal and homozygous adenosine deaminase-deficient fibroblast cell strains.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7380831

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Demonstration of adenosine deaminase activity in human fibroblast lysosomes.

Authors:  E R Lindley; R L Pisoni
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

2.  Structure of adenosine deaminase mRNAs from normal and adenosine deaminase-deficient human cell lines.

Authors:  G S Adrian; D A Wiginton; J J Hutton
Journal:  Mol Cell Biol       Date:  1984-09       Impact factor: 4.272

3.  Sequence of human adenosine deaminase cDNA including the coding region and a small intron.

Authors:  D A Wiginton; G S Adrian; J J Hutton
Journal:  Nucleic Acids Res       Date:  1984-03-12       Impact factor: 16.971

4.  Adenosine deaminase deficiency with normal immune function. An acidic enzyme mutation.

Authors:  P E Daddona; B S Mitchell; H J Meuwissen; B L Davidson; J M Wilson; C A Koller
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

5.  Biochemical and functional abnormalities in lymphocytes from an adenosine deaminase-deficient patient during enzyme replacement therapy.

Authors:  J J Hutton; D A Wiginton; M S Coleman; S A Fuller; S Limouze; B C Lampkin
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

6.  Transient expression of human adenosine deaminase cDNAs: identification of a nonfunctional clone resulting from a single amino acid substitution.

Authors:  S H Orkin; S C Goff; W N Kelley; P E Daddona
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

7.  Identification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency.

Authors:  D T Bonthron; A F Markham; D Ginsburg; S H Orkin
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

8.  Characterization of normal and mutant adenosine deaminase messenger RNAs by translation and hybridization to a cDNA probe.

Authors:  G S Adrian; D A Wiginton; J J Hutton
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

9.  Somatic mosaicism for a newly identified splice-site mutation in a patient with adenosine deaminase-deficient immunodeficiency and spontaneous clinical recovery.

Authors:  R Hirschhorn; D R Yang; A Israni; M L Huie; D R Ownby
Journal:  Am J Hum Genet       Date:  1994-07       Impact factor: 11.025

10.  Basic defect in the expression of adenosine deaminase in ADA-SCID disease. II. Deficiency of ADA-CRM detected in heterozygote human-Chinese hamster cell hybrids.

Authors:  E Herbschleb-Voogt; J W Scholten; P Meera Khan
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.